J Agric Food Chem 54(25):95739583 McFadden RMT, Larmonier CB, Shehab KW, Midura-Kiela M, Ramalingam R, Harrison CA, Kiela PR (2015) The role of curcumin in modulating colonic microbiota during colitis and colon cancer prevention
Hence an approval in the next one-and-a-half to two years seems unlikely." Chereddi adds, "Hengrui's product is just starting Phase 3 in China, and Innovent's product has approval from the Chinese FDA, but hasn't been filed in India." His conclusion: "Indian generic manufacturers face a limited but real opportunitynot an open market." Shah frames it as a "timing risk, not an inevitability", and flags three gating factors beyond trial requirements: Regulatory scrutiny of novel oral delivery systems, bioavailability concerns specific to Indian populations and intellectual property protection on oral peptide platforms that limits immediate generic replication
Thyroid tumors can be a greater risk for semaglutide users
MIC B12 delivers clinically studied nutrients that play vital roles in fat metabolism and cellular energy
